The global gabapentin market size was estimated at USD 2.25 billion in 2024 and is projected to grow at a CAGR of 5.2% from 2025 to 2030. Data Bridge Market Research analyses that the global gabapentin market which was USD 2,472.84 million in 2022, is expected to reach USD 3,021.80 million by 2030, and is expected to undergo a CAGR of 2.6% during the forecast period 2023-2030. The “tablet” segment is expected to dominate the market due to patient’s preference. This makes them also one of the most commonly purchased black-market drugs. The average price for opioids on the street: [2] [3] Fentanyl street price: around $99 per gram Hydrocodone (Vicodin) street price: $6-8 per pill Hydromorphone (Dilaudid) street price: ranges between $2 to $150 per pill Morphine street price: approximately $5 to $50 per The global Gabapentin market was valued at US$ 2,145.3 million in 2024 and is projected to reach US$ 3,875.6 million by 2032, reflecting a CAGR of 7.6% during the forecast period (2024-2032). The gabapentin market size was valued at USD 2,253.78 million in 2024. The market is projected to grow from USD 2,367.60 million in 2025 to USD 3,768.43 million by 2034, exhibiting a CAGR of 5.3% during 2025–2034. The gabapentin market is driven by the increasing prevalence of neuropathic pain, epilepsy, and other neurological disorders. How much does gabapentin cost? The retail price of gabapentin depends on the dosage, form (tablets, capsules, or liquid), and other factors. Without insurance, a monthly supply of brand-name gabapentin 600 mg tablets costs around $ 511.26. But you may pay about $ 287.90 for a 30-day supply of 300 mg capsules. Gabapentin's U.S. market share for NDC 00093-5277 remains strong at 15-20%, but generic competition could reduce prices by 10% by 2026. Supply chain vulnerabilities may drive short-term price increases of up to 15%, offsetting long-term declines. As generics dominate the space, stakeholders must analyze current trends and project prices to mitigate risks and capitalize on growth. This article delves into Gabapentin's market analysis and price forecasts, drawing on data from industry reports and regulatory insights. The gabapentin market was estimated to be worth of USD 2.1 billion in 2023 and is estimated to expand at 4.9% CAGR from 2024 to 2032, owing to the expanded indications of gabapentin. The global gabapentin market size was valued at USD 2.10 Billion in 2024, driven by the increasing use of gabapentin as a pain reliever drug across the globe. The market is anticipated to grow at a CAGR of 5.00% during the forecast period of 2025-2034 to achieve a value of USD 3.42 Billion by 2034. Gabapentin Market Size and Share Forecast Outlook (2025 to 2035) The global Gabapentin Industry is valued at USD 2,340 million in 2025. Market Analysis and Price Projections for Gabapentin (NDC 00409-1201) Introduction Gabapentin, identified by its National Drug Code (NDC) 00409-1201, has emerged as a cornerstone in the pharmaceutical market for treating neuropathic pain, seizures, and restless leg syndrome. The StreetRx Program captures the “black market” or “street price” of prescription drugs by employing crowdsourcing principles. North America is on pace to surpass USD 1.47 billion by 2037, driven by growing prevalence of chronic pain conditions and high demand for gabapentin in the United States and Canada. The growth of the market can be propelled by the increasing number of people suffering from epilepsy. The cost of gabapentin on the streets varies depending on where you live, whether or not it’s a controlled substance in your state, and how much you’re buying. Gabapentin Market Overview Gabapentin is a pharmaceutical drug widely used in the management of neurological conditions, particularly epilepsy and neuropathic pain. The average street price of Flexeril is $1 to $10 per tablet. Gabapentin Gabapentin is a non-opioid pain reliever that can produce mild euphoric and sedative effects. The average street price of Gabapentin is $2 to $5 per pill, depending on the strength. Trazodone Trazodone is a serotonin modulator prescribed for depression and sleep. The global gabapentin market size was valued at USD 2.1 billion in 2023, driven by rising incidence of diabetes across the globe. The market size is anticipated to grow at a CAGR of 4.97% during the forecast period of 2024-2032 to achieve a value of USD 3.76 billion by 2032. In terms of revenue, the global gabapentin market was valued at approximately USD 2.1 billion in 2023, and it is projected to grow at a compound annual growth rate (CAGR) of 4.9% over the forecast period from 2024 to 2032. Compare prescription drug prices and find coupons at more than 70,000 US pharmacies. Save up to 80% instantly!
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |